k 2017

Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study

ERIKSSON, Mikael, Magdalena RYCHLOWSKA-PRUSZYŇSKA, Monica CSOKA, Edita KABÍČKOVÁ, Peter MÚDRY et. al.

Basic information

Original name

Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study

Authors

ERIKSSON, Mikael (752 Sweden), Magdalena RYCHLOWSKA-PRUSZYŇSKA (616 Poland), Monica CSOKA (348 Hungary), Edita KABÍČKOVÁ (203 Czech Republic), Peter MÚDRY (203 Czech Republic, guarantor, belonging to the institution), Pia LISJÖ (752 Sweden) and Karin GANLÖV (752 Sweden)

Edition

38th Meeting of the Scandinavian Sarcoma Group, 2017

Other information

Language

English

Type of outcome

Prezentace na konferencích

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Denmark

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/17:00098889

Organization unit

Faculty of Medicine

Keywords in English

high-dose methotrexate

Tags

Změněno: 16/3/2018 15:26, Soňa Böhmová

Abstract

V originále

Poster Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study.